SSA
IMVT icon

Schonfeld Strategic Advisors’s Immunovant IMVT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$833K Buy
+33,553
New +$869K 0.01% 1177
2025
Q4 		– Sell
-115,750
Closed -$1.87M – 2281
2025
Q3 		$1.87M Buy
+115,750
New +$1.87M 0.01% 1069
2024
Q4 		– Sell
-98,274
Closed -$2.8M – 2189
2024
Q3 		$2.8M Buy
98,274
+76,047
+342% +$2.24M 0.02% 749
2024
Q2 		$587K Buy
+22,227
New +$632K ﹤0.01% 1423
2023
Q3 		– Sell
-55,475
Closed -$1.05M – 2002
2023
Q2 		$1.05M Buy
55,475
+17,813
+47% +$332K 0.01% 948
2023
Q1 		$584K Sell
37,662
-64,123
-63% -$1.11M 0.01% 1123
2022
Q4 		$1.81M Sell
101,785
-15,639
-13% -$197K 0.02% 863
2022
Q3 		$656K Buy
+117,424
New +$574K 0.01% 1553
2021
Q4 		– Sell
-24,400
Closed -$212K – 2325
2021
Q3 		$212K Sell
24,400
-25,600
-51% -$231K ﹤0.01% 1734
2021
Q2 		$529K Sell
50,000
-5,303
-10% -$74K 0.01% 1163
2021
Q1 		$887K Buy
55,303
+36,674
+197% +$967K 0.01% 945
2020
Q4 		$860K Sell
18,629
-26,283
-59% -$1.22M 0.01% 862
2020
Q3 		$1.58M Buy
44,912
+10,512
+31% +$316K 0.03% 577
2020
Q2 		$837K Buy
+34,400
New +$737K 0.02% 659
2020
Q1 		– Sell
-85,000
Closed -$1.35M – 1319
2019
Q4 		$1.35M Buy
+85,000
New +$952K 0.03% 424

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Schonfeld Strategic Advisors's IMVT Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Immunovant (IMVT) in Q1 2026: 33,553 shares worth $833K. The stake represents 0.01% of the portfolio and ranks #1177 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in IMVT as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in IMVT in Q4 2019 and has held it in 15 quarters since. The position peaked at $2.8M in Q3 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Schonfeld Strategic Advisors held 33,553 shares of Immunovant worth $833K as of Q1 2026.
  • Immunovant was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Immunovant made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1177 holding.
  • Schonfeld Strategic Advisors first reported a position in Immunovant in Q4 2019 and has held it in 15 quarters since.
  • Schonfeld Strategic Advisors's Immunovant position peaked at $2.8M in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.